Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 12—December 2010

Hantavirus Pulmonary Syndrome in Argentina, 1995–2008

Valeria P. MartinezComments to Author , Carla M. Bellomo, María Luisa Cacace, Paola Suárez, Liliana Bogni, and Paula J. Padula
Author affiliations: Author affiliations: Administración Nacional de Laboratorios e Institutos de Salud “Dr. C. G. Malbrán,” Buenos Aires, Argentina (V.P. Martinez, C.M. Bellomo, P.J. Padula); Hospital San Vicente de Paul de la Nueva Orán, Salta, Argentina (M.L. Cacace); Hospital Descentralizado–Región Sanitaria XI–Ministerio de Salud de la Provincia de Buenos Aires, Buenos Aires (P. Suarez); Área Programática Esquel–Secretaría de Salud de la Provincia de Chubut, Esquel, Argentina (L. Bogni)

Main Article

Table 1

Demographic characteristics of case-patients who had laboratory-confirmed HPS, by region, Argentina, 1995–2008*

No. case-patients (no. deaths)†
Total 345 (59) 234 (72) 126 (51) 6
M 290 (45) 170 (49) 89 (33) 4
F 52 (14) 64 (23) 37 (18) 2
Case-fatality rate for all case-patients, %
Type of exposure
Rural 111 34 22 1
Wild 34 20 17 1
Peridomestic 28 26 13 2
Contact with previous HPS case-patient 6 23
Other 25 30 6
Total 208 116 81 4

*HPS, hantavirus pulmonary syndrome; –, no reported events.
†No. HPS cases in each region with confirmed diagnosis (n = 710). Type of exposure was classified on the basis of the most probable activities of risk (n = 410).

Main Article

Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.